Access cutting-edge schizophrenia disorder treatment through this clinical trial at a research site in Glen Oaks. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Glen Oaks location
Preparing your pre-screening questions…
Access schizophrenia disorder specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related schizophrenia disorder treatment provided free
Check if you qualify for this schizophrenia disorder clinical trial in Glen Oaks, NY
No-Cost Study Care
Local to Glen Oaks
Convenient for NY residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This study investigates whether tiny molecules called microRNAs (miRNAs), found in special brain-derived "packages" (neural-derived extracellular vesicles, or NDEs) that travel from the brain into the blood, can serve as helpful indicators (biomarkers) for schizophrenia. Currently, doctors diagnose schizophrenia and monitor treatment primarily through clinical interviews, which can be slow and imprecise. This study will work with 80 individuals recently diagnosed with first-episode schizophrenia who are beginning treatment with either aripiprazole or risperidone, along with 80 healthy volunteers. Blood samples will be collected from all participants. For individuals with schizophrenia, blood will be drawn at the beginning of treatment and again after 12 weeks. By comparing patterns of brain-derived miRNAs in the blood of patients versus healthy volunteers, and by observing changes in these miRNAs during treatment, the researchers hope to discover whether these molecules can help diagnose schizophrenia more quickly and predict how well a treatment will work. If successful, this study will provide initial evidence that these miRNAs could become valuable new tools leading to earlier, more accurate diagnoses and more personalized treatment selection.
Sponsor: Northwell Health
Yes, this clinical trial (NCT07703670) has an active research site in Glen Oaks, NY that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for schizophrenia disorder treatment options in Glen Oaks, NY, this clinical trial (NCT07703670) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Glen Oaks research site is actively enrolling participants for this clinical trial. You'll receive care from experienced schizophrenia disorder specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all schizophrenia disorder clinical trials near you to find additional studies recruiting in your area.
See all schizophrenia clinical trials recruiting in Glen Oaks — not just this study.
Browse Schizophrenia Trials in Glen Oaks →